These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10911375)

  • 1. Fibrinogen bellingham: a gamma-chain R275C substitution and a beta-promoter polymorphism in a thrombotic member of an asymptomatic family.
    Linenberger ML; Kindelan J; Bennett RL; Reiner AP; Côté HC
    Am J Hematol; 2000 Aug; 64(4):242-50. PubMed ID: 10911375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, BbetaGly15Cys (Hamamatsu II).
    Kamijyo Y; Hirota-Kawadobora M; Yamauchi K; Terasawa F; Honda T; Ikeya M; Okumura N
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):726-32. PubMed ID: 19809304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial deletion of the αC-domain in the Fibrinogen Perth variant is associated with thrombosis, increased clot strength and delayed fibrinolysis.
    Westbury SK; Duval C; Philippou H; Brown R; Lee KR; Murden SL; Phillips E; Reilly-Stitt C; Whalley D; Ariëns RA; Mumford AD
    Thromb Haemost; 2013 Dec; 110(6):1135-44. PubMed ID: 24048413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dusart Syndrome in a Scandinavian family characterized by arterial and venous thrombosis at young age.
    Ramanathan R; Gram J; Feddersen S; Nybo M; Larsen A; Sidelmann JJ
    Scand J Clin Lab Invest; 2013 Oct; 73(7):585-90. PubMed ID: 24000886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis.
    Robert-Ebadi H; Le Querrec A; de Moerloose P; Gandon-Laloum S; Borel Derlon A; Neerman-Arbez M
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):697-9. PubMed ID: 18832913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysfibrinogenemia-associated novel heterozygous mutation, Shanghai (FGA c.169_180+2 del), leads to N-terminal truncation of fibrinogen Aα chain and impairs fibrin polymerization.
    Zhou J; Ding Q; Wu W; Ouyang Q; Xie Y; Wu X; Lu Y; Dai J; Liang Q; Wang H; Wang X; Hu Y
    J Clin Pathol; 2017 Feb; 70(2):145-153. PubMed ID: 27555433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two cases of congenital dysfibrinogenemia associated with thrombosis - Fibrinogen Praha III and Fibrinogen Plzen.
    Kotlín R; Reicheltová Z; Malý M; Suttnar J; Sobotková A; Salaj P; Hirmerová J; Riedel T; Dyr JE
    Thromb Haemost; 2009 Sep; 102(3):479-86. PubMed ID: 19718467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen Bbeta14 Arg-->Cys: further evidence for a role in thrombosis.
    Vakalopoulou S; Mille-Baker B; Mumford A; Manning R; Laffan M
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):403-8. PubMed ID: 10695765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
    Niwa K; Mimuro J; Miyata M; Sugo T; Ohmori T; Madoiwa S; Tei C; Sakata Y
    Thromb Res; 2008; 121(6):773-80. PubMed ID: 17854865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exome Sequencing and Clot Lysis Experiments Demonstrate the R458C Mutation of the Alpha Chain of Fibrinogen to be Associated with Impaired Fibrinolysis in a Family with Thrombophilia.
    Fernández-Cadenas I; Penalba A; Boada C; Carrerra C; Bueno SR; Quiroga A; Monasterio J; Delgado P; Anglés-Cano E; Montaner J
    J Atheroscler Thromb; 2016; 23(4):431-40. PubMed ID: 26581183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypodysfibrinogenemia: A novel abnormal fibrinogen associated with bleeding and thrombotic complications.
    Amri Y; Kallel C; Becheur M; Dabboubi R; Elloumi M; Belaaj H; Kammoun S; Messaoud T; de Moerloose P; Toumi Nel H
    Clin Chim Acta; 2016 Sep; 460():55-62. PubMed ID: 27343352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes.
    Greenhalgh KA; Strachan MW; Alzahrani S; Baxter PD; Standeven KF; Storey RF; Ariens RA; Grant PJ; Price JF; Ajjan RA
    Thromb Haemost; 2017 Jan; 117(2):295-302. PubMed ID: 27929198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new type of Ser substitution for gamma Arg-275 in fibrinogen Kamogawa I characterized by impaired fibrin assembly.
    Mimuro J; Kawata Y; Niwa K; Muramatsu S; Madoiwa S; Takano H; Sugo T; Sakata Y; Sugimoto T; Nose K; Matsuda M
    Thromb Haemost; 1999 Jun; 81(6):940-4. PubMed ID: 10404772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexisting dysfibrinogenemia (gammaR275C) and factor V Leiden deficiency associated with thromboembolic disease (fibrinogen Cedar Rapids).
    Siebenlist KR; Mosesson MW; Meh DA; DiOrio JP; Albrecht RM; Olson JD
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):293-304. PubMed ID: 10870810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen.
    Haverkate F; Samama M
    Thromb Haemost; 1995 Jan; 73(1):151-61. PubMed ID: 7740487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from gammaAsn319, Asp320 deletion dysfibrinogen, Otsu I.
    Terasawa F; Kani S; Hongo M; Okumura N
    Thromb Res; 2006; 118(5):651-61. PubMed ID: 16412498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mutation in exon 2 of FGB caused by c.221G>T
    Shlebak AA; Katsarou AD; Adams G; Fernando F
    J Thromb Thrombolysis; 2017 Feb; 43(2):263-270. PubMed ID: 27812779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexisting congenital dysfibrinogenemia with a novel mutation in fibrinogen γ chain (γ322 Phe→Ile, Fibrinogen Beijing) and haemophilia B in a family.
    Hua B; Li K; Lee A; Poon MC; Zhao Y
    Haemophilia; 2015 Nov; 21(6):846-51. PubMed ID: 25982359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Afibrinogenemia resulting from homozygous nonsense mutation in A alpha chain gene associated with multiple thrombotic episodes.
    Simsek I; de Mazancourt P; Horellou MH; Erdem H; Pay S; Dinc A; Samama MM
    Blood Coagul Fibrinolysis; 2008 Apr; 19(3):247-53. PubMed ID: 18388508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two novel fibrinogen variants in the C-terminus of the Bβ-chain: fibrinogen Rokycany and fibrinogen Znojmo.
    Kotlín R; Reicheltová Z; Suttnar J; Salaj P; Hrachovinová I; Riedel T; Malý M; Oravec M; Kvasnicka J; Dyr JE
    J Thromb Thrombolysis; 2010 Oct; 30(3):311-8. PubMed ID: 20640913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.